Tag Archives: mergers

November, 2018

December, 2017

  • 22 December

    Roche to Acquire Cancer Medicine Specialist Ignyta for $1.7 Billion

    SAN DIEGO–(BUSINESS WIRE)–Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. (NASDAQ: RXDX) today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta at a price of US$ 27.00 per share in an all-cash transaction. This corresponds to a total transaction value of US$ …

  • 4 December

    CVS Health to Acquire Health Insurer Aetna for $69 Billion

    WOONSOCKET, R.I. and HARTFORD, Conn., Dec. 3, 2017 /PRNewswire/ — CVS Health (NYSE: CVS), a company at the forefront of changing the health care landscape, and Aetna (NYSE: AET), one of the nation’s leading diversified health care benefits companies, today announced the execution of a definitive merger agreement under which CVS Health will acquire …

May, 2017

  • 10 May

    INC Research and InVentiv Health to Merge in $4.6 Billion Deal

    RALEIGH, NC and BOSTON, MA, May 10, 2017 – INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I–IV Contract Research Organization (“CRO”), and inVentiv Health, Inc., a leading, privately held, global CRO and Contract Commercial Organization (“CCO”), today announced that their Boards of Directors have unanimously approved a definitive …

October, 2016

August, 2016

June, 2016

  • 6 June

    Shire Completes $32 Billion Takeover of Baxalta

    Dublin, Ireland – June 3, 2016 – Shire plc (LSE: SHP, NASDAQ: SHPG) today completed its previously announced combination with Baxalta Incorporated (NYSE: BXLT), creating the leading global biotechnology company focused on serving patients with rare diseases and other highly specialized conditions. Through the combination, Shire expects to deliver double-digit …

May, 2016

  • 4 May

    IMS Health and Quintiles to Merge in $9 Billion Deal

    DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc. (NYSE:Q): Broad range of healthcare information, technology and services solutions to drive efficiencies and insights across the entire life sciences product lifecycle, from R&D through commercial execution to real-world patient outcomes. Capabilities to …

November, 2015

  • 23 November

    Pfizer and Allergan Confirms $160 Billion Merger Deal

    NEW YORK & DUBLIN–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) and Allergan plc (NYSE:AGN) today announced that their boards of directors have unanimously approved, and the companies have entered into, a definitive merger agreement under which Pfizer, a global innovative biopharmaceutical company, will combine with Allergan, a global pharmaceutical company and a leader …